Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Krishna Padmanabhan
S. Krishna Padmanabhan
Placebo
Desvenlafaxine
Psychiatry
Major depressive disorder
Anesthesia
6
Papers
133
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A 10-Month, Open-Label Evaluation of Desvenlafaxine in Outpatients With Major Depressive Disorder
2011
The Primary Care Companion To The Journal of Clinical Psychiatry
Karen A. Tourian
Bruno Pitrosky
S. Krishna Padmanabhan
Gregory Rosas
Show All
Source
Cite
Save
Citations (10)
Adaptive Approaches in Clinical Drug Development: Opportunities and Challenges in Design and Implementation
2009
Pharmaceutical medicine
Michael Krams
Amarnath Sharma
Vlad Dragalin
Daniel D. Burns
Parvin Fardipour
S. Krishna Padmanabhan
Inna Perevozskaya
Gary S. Littman
Robert Maguire
Show All
Source
Cite
Save
Citations (1)
Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: An 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies
2009
Clinical Therapeutics
Karen A. Tourian
S. Krishna Padmanabhan
James Groark
Claudine Brisard
Deborah Farrington
Show All
Source
Cite
Save
Citations (51)
A placebo-controlled study evaluating the efficacy and safety of flexible-dose desvenlafaxine treatment in outpatients with major depressive disorder.
2009
Cns Spectrums
Alan D. Feiger
Karen A. Tourian
Gregory Rosas
S. Krishna Padmanabhan
Show All
Source
Cite
Save
Citations (39)
Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo
2005
International Clinical Psychopharmacology
Charles Shelton
Richard Entsuah
S. Krishna Padmanabhan
Phillip E. Vinall
Show All
Source
Cite
Save
Citations (30)
1